World Investment Advisors
IBRX icon

World Investment Advisors’s ImmunityBio IBRX Stock Holding History

World Investment Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.7K Sell
11,179
-7,900
-41% -$59.8K ﹤0.01% 1503
2026
Q1 		$146K Buy
+19,079
New +$131K ﹤0.01% 1511

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

World Investment Advisors's IBRX Position: Q2 2026 in Review

World Investment Advisors reduced its ImmunityBio (IBRX) stake by 41% in Q2 2026, selling an estimated $59.8K and leaving 11,179 shares worth $85.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

World Investment Advisors first reported a position in IBRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $146K in Q1 2026. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • World Investment Advisors held 11,179 shares of ImmunityBio worth $85.7K as of Q2 2026.
  • World Investment Advisors sold 7,900 ImmunityBio shares in Q2 2026, an estimated $59.8K.
  • ImmunityBio made up ﹤0.01% of World Investment Advisors's portfolio in Q2 2026, its #1503 holding.
  • World Investment Advisors first reported a position in ImmunityBio in Q1 2026 and has held it in 2 quarters since.
  • World Investment Advisors's ImmunityBio position peaked at $146K in Q1 2026.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.